OpenBCI develops open-source biosensing hardware and software tools designed to support brain–computer interface research and development. The company’s product portfolio includes modular EEG, EMG, and EKG systems, as well as Galea, a multimodal biosensing platform built for extended reality applications. Its approach emphasizes accessibility, transparency, and extensibility for researchers and developers. OpenBCI positions its technology within research, prototyping, and developer ecosystems rather than proprietary clinical products.

The technology provides non-invasive biosignal acquisition through configurable hardware paired with open-source software. Galea combines EEG with additional biometric sensors to enable synchronized measurement of neural and physiological signals during immersive XR experiences. Software tools support real-time data streaming, signal processing, and integration with third-party platforms. This open architecture allows users to customize systems for diverse experimental and interactive use cases.

OpenBCI targets researchers, developers, and educators working in neuroscience, human–computer interaction, and BCI prototyping. The platforms are intended for non-clinical, experimental use rather than regulated medical diagnostics. Its positioning reflects continued demand for open, developer-friendly biosensing tools that enable innovation and collaboration across the neurotechnology community.